European Journal of Experimental Biology Open Access

  • ISSN: 2248-9215
  • Journal h-index: 45
  • Journal CiteScore: 34.35
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Targeting TLR4 with novel carbohydrate ligands

International Conference on Glycobiology
September 21-22, 2017 HOUSTON, TX, USA

Cecilia H Marzabadi

Seton Hall University, USA

Posters & Accepted Abstracts: Eur J Exp Bio

Abstract:

The development of novel TLR4 agonists for use as immunomodulators and as adjuvants for vaccines is becoming increasingly important. TLR4 signaling occurs through both MyD88- dependent, as well as, MyD88-independent pathways, thus allowing for a robust immune response to the antigen. Achieving the proper balance between activation of different T-cell subtypes is the challenge in chemical modification of the structure of the agonist. Our efforts toward the synthesis and biological evaluation of novel carbohydrate structures that elicit immunomstimulatory responses will be presented.